BWC0977, a novel bacterial topoisomerase inhibitor, has demonstrated efficacy against multi-drug resistant pathogens, including strains resistant to fluoroquinolones and carbapenems.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.